Below are the financial statements of Bio-Techne, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2025 as of 2025-06-30 | 2024 as of 2024-06-30 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 162.19a | 151.79a |
| Short-term available-for-sale investments | 0a | 1.07a |
| Accounts receivable, less allowances | 206.88a | 241.39a |
| Inventories | 189.45a | 179.73a |
| Current assets held-for-sale | 12.33a | 9.77a |
| Other current assets | 37.46a | 33.66a |
| Total current assets | 608.3a | 617.42a |
| Property and equipment, net | 245.72a | 251.15a |
| Right-of-use assets | 73.4a | 91.29a |
| Goodwill | 980.94a | 972.66a |
| Intangible assets, net | 365.6a | 507.08a |
| Deferred tax asset | 10.31a | 0a |
| Other assets | 273.61a | 264.27a |
| Total assets | 2,557.87a | 2,703.87a |
| Liabilities and shareholders’ equity | — | — |
| Current liabilities | — | — |
| Trade accounts payable | 25.31a | 37.97a |
| Salaries, wages and related accruals | 65.79a | 49.82a |
| Accrued expenses | 25.66a | 24.89a |
| Contract liabilities | 32.57a | 27.93a |
| Income taxes payable | 10.77a | 3.71a |
| Operating lease liabilities - current | 14.1a | 12.92a |
| Other current liabilities | 1.65a | 2.15a |
| Total current liabilities | 175.85a | 159.38a |
| Deferred income taxes | 6.17a | 55.86a |
| Long-term debt obligations | 346a | 319a |
| Operating lease liabilities | 83.96a | 87.62a |
| Other long-term liabilities | 27.08a | 13.16a |
| Shareholders’ equity | — | — |
| Undesignated capital stock | 0a | 0a |
| Common stock | 1.55a | 1.58a |
| Additional paid-in capital | 911.09a | 820.34a |
| Retained earnings | 1,066.05a | 1,325.25a |
| Accumulated other comprehensive loss | -59.88a | -78.32a |
| Total shareholders’ equity | 1,918.81a | 2,068.85a |
| Total liabilities and shareholders’ equity | 2,557.87a | 2,703.87a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.